Position in CLLS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$94,382
-$148,100 QoQ
Shares Held
29,774
-40.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CLLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. CLLS ranks #367 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in CLLS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,382 | 29,774 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $242,482 | 50,100 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $83,500 | 29,299 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $39,084 | 25,629 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,149 | 44,475 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $412,345 | 229,081 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $308 | 100 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,375 | 4,035 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $636 | 330 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,438 | 5,447 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $8,946 | 3,907 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,114 | 394 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $12,566 | 2,768 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $82,222 | 10,126 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $205,568 | 16,302 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $227,594 | 14,712 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,478,765 | 73,170 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,816,266 | 67,120 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,453,471 | 78,566 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $350,339 | 19,682 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $279,863 | 30,420 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||